SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010194
Filing Date
2024-03-18
Accepted
2024-03-18 08:00:26
Documents
14
Period of Report
2024-03-12
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42278
  Complete submission text file 0001493152-24-010194.txt   265910

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tcbp-20240312.xsd EX-101.SCH 4054
3 XBRL DEFINITION FILE tcbp-20240312_def.xml EX-101.DEF 27117
4 XBRL LABEL FILE tcbp-20240312_lab.xml EX-101.LAB 37512
5 XBRL PRESENTATION FILE tcbp-20240312_pre.xml EX-101.PRE 25737
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6895
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41231 | Film No.: 24756954
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)